tiprankstipranks
Insecticides (India) Limited (IN:INSECTICID)
:INSECTICID
India Market

Insecticides (India) Limited (INSECTICID) AI Stock Analysis

2 Followers

Top Page

IN:INSECTICID

Insecticides (India) Limited

(INSECTICID)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 5.2)
Rating:59Neutral
Price Target:
₹609.00
▼(-14.30% Downside)
Action:ReiteratedDate:04/02/26
The score is supported primarily by solid financial performance (growth, improving profitability, and healthy cash generation), but is held back by weak technicals (downtrend and negative momentum) and an elevated valuation (high P/E with low dividend yield).
Positive Factors
Consistent Revenue Growth
Sustained revenue expansion from 2021–2025 indicates growing market penetration and stronger distribution reach in the domestic agrochemical market. Over 2–6 months this scale supports repeatable cash generation, bargaining power with suppliers, and resources for product development and channel support.
Negative Factors
Rising Total Liabilities
A steady increase in total liabilities may erode financial headroom and increase interest or covenant exposure over time. If liabilities grow faster than equity or cash generation, the company could face tighter liquidity and reduced flexibility for strategic investments or to absorb adverse farm-cycle shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Sustained revenue expansion from 2021–2025 indicates growing market penetration and stronger distribution reach in the domestic agrochemical market. Over 2–6 months this scale supports repeatable cash generation, bargaining power with suppliers, and resources for product development and channel support.
Read all positive factors

Insecticides (India) Limited (INSECTICID) vs. iShares MSCI India ETF (INDA)

Insecticides (India) Limited Business Overview & Revenue Model

Company Description
Insecticides (India) Limited manufactures and sells agro chemicals, pesticides, and technical products for agriculture purposes in India and internationally. The company offers insecticides, herbicides, fungicides, and PGRs and bio fertilizers. It...
How the Company Makes Money
The company primarily makes money by selling agrochemical crop-protection products. Its main revenue stream comes from the domestic sale of formulated/branded crop-protection chemicals (e.g., insecticides, herbicides, fungicides) distributed throu...

Insecticides (India) Limited Financial Statement Overview

Summary
Strong overall fundamentals supported by consistent revenue growth (2021–2025), improved gross and net margins, and healthy cash generation. Offsetting factors include fluctuating EBIT margins, rising total liabilities, and some free-cash-flow volatility.
Income Statement
82
Very Positive
Balance Sheet
78
Positive
Cash Flow
75
Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue20.45B20.00B19.56B17.97B14.98B14.12B
Gross Profit6.82B3.98B2.82B3.99B3.79B3.35B
EBITDA2.43B2.29B1.72B1.21B1.73B1.48B
Net Income1.48B1.42B1.02B632.11M1.07B939.03M
Balance Sheet
Total Assets19.97B18.98B17.13B16.96B13.96B14.26B
Cash, Cash Equivalents and Short-Term Investments440.95M666.26M613.50M196.42M360.96M81.44M
Total Debt2.46B1.05B873.09M1.63B539.50M1.00B
Total Liabilities7.94B8.14B7.00B7.78B5.27B6.06B
Stockholders Equity12.03B10.85B10.14B9.18B8.70B8.20B
Cash Flow
Free Cash Flow-1.62B561.68M1.35B-980.91M675.70M1.07B
Operating Cash Flow-1.21B934.57M1.84B-106.33M1.35B1.55B
Investing Cash Flow-375.08M-377.20M-429.91M-864.03M93.09M-1.13B
Financing Cash Flow1.30B-610.92M-980.58M796.80M-1.15B-1.04B

Insecticides (India) Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price710.65
Price Trends
50DMA
604.79
Positive
100DMA
648.99
Negative
200DMA
754.48
Negative
Market Momentum
MACD
-11.02
Negative
RSI
54.64
Neutral
STOCH
60.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INSECTICID, the sentiment is Neutral. The current price of 710.65 is above the 20-day moving average (MA) of 581.94, above the 50-day MA of 604.79, and below the 200-day MA of 754.48, indicating a neutral trend. The MACD of -11.02 indicates Negative momentum. The RSI at 54.64 is Neutral, neither overbought nor oversold. The STOCH value of 60.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:INSECTICID.

Insecticides (India) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹9.94B11.481.06%16.68%15.13%
68
Neutral
₹29.94B8.712.00%17.71%18.17%
67
Neutral
₹1.86B3.788.83%160.77%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
59
Neutral
₹17.67B49.770.71%6.86%15.64%
46
Neutral
₹21.83B39.15-11.72%-439.12%
46
Neutral
₹286.52M-0.44
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:INSECTICID
Insecticides (India) Limited
607.25
27.73
4.78%
IN:ANDHRSUGAR
Andhra Sugars Limited
73.36
6.58
9.85%
IN:BAJAJHIND
Bajaj Hindusthan Sugar Limited
17.09
-0.43
-2.45%
IN:DALMIASUG
Dalmia Bharat Sugar & Industries Ltd.
369.85
20.71
5.93%
IN:DHARSUGAR
Dharani Sugars & Chemicals Ltd.
IN:RANASUG
Rana Sugars Limited
12.12
-0.69
-5.39%

Insecticides (India) Limited Corporate Events

Insecticides (India) Clears Q3 FY26 Results, Declares Interim Dividend
Jan 30, 2026
Insecticides (India) Limited’s board has approved the unaudited standalone and consolidated financial results for the third quarter and nine months ended 31 December 2025, following review and recommendation by the audit committee and a limi...
Insecticides (India) Reports No Re‑lodgement Requests for Physical Share Transfers
Jan 3, 2026
Insecticides (India) Limited has notified the stock exchanges that, in line with a SEBI circular governing the special window for re-lodgement of transfer requests for physical shares, it has received a status report from its Registrar and Share T...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 02, 2026